In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation.
Masashi YanakiMasayuki KobayashiAtsushi ArugaMinoru NomuraMakoto OzakiPublished in: Integrative cancer therapies (2018)
MK615 is beneficial for a prolonged host survival time in the B16/BL6 melanoma xenograft model associated with T cell-mediated antitumor immunity.